Microbot Medical Inc. (NASDAQ:MBOT) shares are trading higher Monday after the company announced that it has received FDA approval to proceed with its human clinical trial as part of its ...
Fintel reports that on December 3, 2025, Roth Capital initiated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. As of November 17, 2025, the average one-year price target for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results